Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical features

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Breast Cancer Research and Treatment

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10549-010-1248-6PMID 21069451PMCID PMC3677189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fhit loss in lung preneoplasia: relation to DNA damage response checkpoint activation.

  2010cited by this paper
• Emergence of rationally designed therapeutic strategies for breast cancer targeting DNA repair mechanisms

  2010cited by this paper
• Concomitant loss of heterozygosity at the BRCA1 and FHIT genes as a prognostic factor in sporadic breast cancer.

  2010cited by this paper
• Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins

  2010cited by this paper
• Identification of primary gene targets of TFAP2C in hormone responsive breast carcinoma cells

  2010cited by this paper
• WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.

  2009cited by this paper
• Subcellular localization of the HER4 intracellular domain, 4ICD, identifies distinct prognostic outcomes for breast cancer patients.

  2009cited by this paper
• Fragile histidine triad protein, WW domain‐containing oxidoreductase protein Wwox, and activator protein 2γ expression levels correlate with basal phenotype in breast cancer

  2009cited by this paper
• [Effects of WWOX on ovarian cancer cell attachment in vitro].

  2009cited by this paper
• Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• [Effect of WWOX gene on the attachment and adhesion of ovarian cancer cells].

  2009cited by this paper
• Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.

  2009cited by this paper
• Clinical relevance of the triple-negative breast cancer concept: genetic basis and clinical utility of the concept.

  2009cited by this paper
• Fhit tumor suppressor: guardian of the preneoplastic genome.

  2008cited by this paper
• Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study

  2008cited by this paper
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• Therapeutic Strategies for Triple-Negative Breast Cancer

  2008cited by this paper
• Replication stress induces tumor-like microdeletions in FHIT/FRA3B

  2008cited by this paper
• Role of ErbB4 in Breast Cancer

  2008cited by this paper
• BRCA1 regulates human mammary stem/progenitor cell fate

  2008cited by this paper
• Fhit-deficient hematopoietic stem cells survive hydroquinone exposure carrying precancerous changes.

  2008cited by this paper
• DNA damage signalling guards against activated oncogenes and tumour progression

  2007cited by this paper
• Association of Wwox with ErbB4 in breast cancer.

  2007cited by this paper
• A Fhit-ing Role in the DNA Damage Checkpoint Response

  2007cited by this paper
• Wwox and Ap2gamma expression levels predict tamoxifen response.

  2007cited by this paper
• The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.

  2007cited by this paper
• Wwox and Ap2γ Expression Levels Predict Tamoxifen Response

  2007cited by this paper
• Common fragile sites as targets for chromosome rearrangements.

  2006cited by this paper
• GammaH2AX and its role in DNA double-strand break repair.

  2006cited by this paper
• Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling

  2006cited by this paper
• BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution

  2006cited by this paper
• Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

  2005cited by this paper
• Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions

  2005cited by this paper
• DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis

  2005cited by this paper
• Sensing, signaling, and responding to DNA damage: Organization of the checkpoint pathways in mammalian cells

  2005cited by this paper
• Concordant loss of fragile gene expression early in breast cancer development

  2005cited by this paper
• Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

  2005cited by this paper
• Cell-cycle checkpoints and cancer

  2004cited by this paper
• Breast cancer, stem/progenitor cells and the estrogen receptor.

  2004cited by this paper
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004cited by this paper
• The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma

  2004cited by this paper
• Stem cells and breast cancer: A field in transit

  2003cited by this paper
• The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.

  2002cited by this paper
• Nuclear receptor community goes virtual

  2002cited by this paper
• Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

  2001cited by this paper
• Regressions by Leaps and Bounds

  2000cited by this paper
• Reduced Fhit expression in sporadic and BRCA2-linked breast carcinomas.

  1999cited by this paper
• NCCN Internet-based data system for the conduct of outcomes research.

  1998cited by this paper
• NCCN Internet-based data system for the conduct of outcomes research.

  1998cited by this paper
• Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

  1998cited by this paper

• The Landscape of Potential Targeted Treatments and Chemotherapy Efficacy Biomarkers for TNBC

  2025cites this paper
• Piyasada Satılan Farklı Formlardaki Ganoderma lucidum Preparatlarında Antioksidan Kapasitenin Karşılaştırılması

  2024cites this paper
• Unveiling the relationship between WWOX and BRCA1 in mammary tumorigenicity and in DNA repair pathway selection

  2024cites this paper
• An image analysis approach to characterize micronuclei differences in different subtypes of breast cancer.

  2024cites this paper
• Wwox Binding to the Murine Brca1-BRCT Domain Regulates Timing of Brip1 and CtIP Phospho-Protein Interactions with This Domain at DNA Double-Strand Breaks, and Repair Pathway Choice

  2022cites this paper
• DNA damage response inhibitors: An avenue for TNBC treatment.

  2021cites this paper
• Interaction of Wwox with Brca1 and associated complex proteins prevents premature resection at double-strand breaks and aberrant homologous recombination.

  2021cites this paper
• Molecular Functions of WWOX Potentially Involved in Cancer Development

  2021cites this paper
• WWOX Gen İfadesinin Kronik Lenfositik Lösemi ile İlişkisi

  2020cites this paper
• Microsatellite Instability of BAT-26 and NR-24among Breast Cancer Patients in Senegal

  2019cites this paper
• Metallic air pollutants and breast cancer heterogeneity.

  2019cites this paper
• Biological rationale for a patient-specific approach in the treatment of breast cancer. Clinical value of novel biomarkers of breast cancer

  2019cites this paper
• Antioxidant and antimicrobial capacities of Ganoderma lucidum

  2019cites this paper
• BIOCHEMICAL AND MOLECULAR MARKERS IN BREAST CANCER PATIENTS

  2019cites this paper
• Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.

  2018cites this paper
• DNA primase polypeptide 1 (PRIM1) involves in estrogen‐induced breast cancer formation through activation of the G2/M cell cycle checkpoint

  2018cites this paper
• WWOX Phosphorylation, Signaling, and Role in Neurodegeneration

  2018cites this paper
• WWOX Tumor Suppressor Gene in Breast Cancer, a Historical Perspective and Future Directions

  2018cites this paper
• Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2/STAT3 axis

  2018cites this paper
• Modeling WWOX Loss of Function in vivo: What Have We Learned?

  2018cites this paper
• Correlation of expression of WWOX and JNK with clinicopathologic features in human breast carcinoma.

  2018cites this paper
• Somatic loss of WWOX is associated with TP53 perturbation in basal-like breast cancer

  2018cites this paper
• Long non-coding RNA TUG1 promotes cell proliferation and metastasis in human breast cancer

  2017cites this paper
• DNA repair and damage pathways in breast cancer development and therapy.

  2017cites this paper
• Fragile Genes That Are Frequently Altered in Cancer: Players Not Passengers

  2017cites this paper
• Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients

  2016cites this paper
• Protein phosphatase Mg2+/Mn2+ dependent 1F promotes smoking-induced breast cancer by inactivating phosphorylated-p53-induced signals

  2016cites this paper
• The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer

  2016cites this paper
• Study of Atm and Chek2 Genes Snps and Their Association with Breast Cancer

  2016cites this paper
• Fatty acid binding protein 5 promotes metastatic potential of triple negative breast cancer cells through enhancing epidermal growth factor receptor stability

  2015cites this paper
• A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments

  2015cites this paper
• WWOX: A fragile tumor suppressor

  2015cites this paper
• High Levels of Nucleolar Spindle-Associated Protein and Reduced Levels of BRCA1 Expression Predict Poor Prognosis in Triple-Negative Breast Cancer

  2015cites this paper
• Transcriptome analysis of breast cancer in African American women

  2015cites this paper
• Strategies of oncogenic microbes to deal with WW domain-containing oxidoreductase

  2015cites this paper
• Alteration of WWOX in human cancer, a clinical view

  2015influential citation
• Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer

  2015cites this paper
• Pathway-centric analysis of the DNA damage response to chemotherapeutic agents in two breast cell lines

  2015cites this paper
• WW domain-containing oxidoreductase’s role in myriad cancers: Clinical significance and future implications

  2014cites this paper
• γδ T Cells and Their Potential for Immunotherapy

  2014cites this paper
• Androgen Receptor Status Is a Prognostic Marker in Non-Basal Triple Negative Breast Cancers and Determines Novel Therapeutic Options

  2014cites this paper
• Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors

  2014cites this paper
• FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis

  2014cites this paper
• Clinicopathological features and prognostic factors of young breast cancers in Eastern Guangdong of China

  2014cites this paper
• Diverse effect of WWOX overexpression in HT29 and SW480 colon cancer cell lines

  2014cites this paper
• Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients.

  2013cites this paper
• Treating metastatic breast cancer with systemic chemotherapies: current trends and future perspectives.

  2012cites this paper
• Stem cell-related markers in primary breast cancers and associated metastatic lesions

  2012cites this paper
• The Significance of Fragile Histidine Triad Protein as a Molecular Prognostic Marker of Bladder Urothelial Carcinoma

  2012cites this paper
• Distinct and Competitive Regulatory Patterns of Tumor Suppressor Genes and Oncogenes in Ovarian Cancer

  2012cites this paper
• Inter- and intra-laboratory study to determine the reproducibility of toxicogenomics datasets.

  2011cites this paper
• DNA damage and breast cancer.

  2011cites this paper